{
    "nct_id": "NCT04044937",
    "official_title": "Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm",
    "inclusion_criteria": "* Age > 3 years.\n* Presence or suspicion of intracranial neoplasm in two populations.\n\n  * Population 1: Patients after primary treatment (radiation therapy and/or surgery) with suspicion of recurrence on magnetic resonance imaging (MRI). Three sub-populations will be considered:\n\n    * Recurrent metastatic lesions.\n    * Recurrent high-grade gliomas (grades 3 and 4).\n    * Recurrent low-grade gliomas (grades 1 and 2).\n  * Population 2: Patients prior to primary treatment with planned biopsy or surgical resection.\nHealthy volunteers allowed\nMust have minimum age of 3 Years",
    "exclusion_criteria": "* Patient with known incompatibility to PET or computed tomography (CT)/MRI scans.\n* Patient unlikely to comply with study procedures, restrictions and requirements and judged by the investigator to be unsuitable for study participation.\n\n  * Sedation or anesthesia can be used for patients who cannot tolerate the exam.",
    "miscellaneous_criteria": ""
}